Complete correction of anemia by erythropoiesis-stimulating agents is associated with insulin resistance in hemodialysis patients

Author： Biolo Gianni   Guarnieri Gianfranco   Barazzoni Rocco   Panzetta Giovanni  

Publisher： Springer Publishing Company

ISSN： 1591-8890

Source： Clinical and Experimental Medicine, Vol.11, Iss.3, 2011-09, pp. : 181-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Effect of Erythropoiesis-Stimulating Agents in Patients with Therapy-Refractory Autoimmune Hemolytic Anemia

By  

Transfusion Medicine and Hemotherapy, Vol. 41, Iss. 6, 2014-09 ,pp. : 462-468

Karger

Access to resources Recommend Favorite

Costs Associated with Erythropoiesis-Stimulating Agent Administration to Hemodialysis Patients

By  

Nephron Clin Pract, Vol. 106, Iss. 4, 2007-06 ,pp. : c193-c198

Karger

Access to resources Recommend Favorite

Use and cost of erythropoiesis-stimulating agents in patients with cancer

By Daniel Gregory   Hurley Dana   Whyte Joanna L.   Willey Vincent   Wilson Marcus   Kallich Joel  

Current Medical Research and Opinion, Vol. 25, Iss. 7, 2009-07 ,pp. : 1775-1784

Informa Healthcare

Access to resources Recommend Favorite

Anemia treatment with Q2W darbepoetin alfa in patients with chronic kidney disease naïve to erythropoiesis-stimulating agents*

By Silver M. R.   Geronemus R.   Krause M.   Chen C. Y.   Kewalramani R.   Stehman-Breen C.  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 123-131

Informa Healthcare

Access to resources Recommend Favorite

Effect of Synthetic Vitamin E-Bonded Membrane on Responsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients: A Pilot Study

By  

Nephron Clin Pract, Vol. 115, Iss. 1, 2010-03 ,pp. : c82-c89

Karger

Access to resources Recommend Favorite